# Stage 12B Quality, Expanded-View, Device, and Input-Rejection Readiness

Stage 12B is a metadata-only audit. It does not retrain Stage 5 or read images. The existing AP, PA, and LATERAL view contract and technical-quality proxy remain frozen.

CheXpert Small provides an image-level `Support Devices` label and is governed for the existing Stage 5 task. This supports consideration of a future independent device-presence head, but it provides no verified device localization. No localization claim is permitted.

No governed local evidence currently supplies explicit `OTHER` and `UNKNOWN` view labels. Missing view metadata is not an `UNKNOWN` label, and unsupported views must not be inferred from filenames. A reviewed annotation protocol and development cohort are required.

A downstream stop contract requires a versioned rejection taxonomy, governed labels, patient-safe development splits where learned components are used, validation-frozen thresholds, per-reason error metrics, and integration tests proving rejected inputs cannot reach disease inference.

No additional download is required to audit device presence. The project owner must approve the expanded-view and bad-input annotation protocol. A separately licensed, identity-resolved dataset with device-location annotations is needed only if device localization is pursued.
